Use of malondialdehyde as a biomarker for assessing oxidative stress in different disease pathologies: A review

Iranian Journal of Public Health

Volumn 43, Issue , 2014, Pages 7-16

  Singh, Zorawar ^a   Karthigesu, Indrakaran P ^b   Singh, Pramjit ^c   Kaur, Rupinder ^a  

^a KHALSA COLLEGE   (India)

^b UNIVERSITY PUTRA MALAYSIA   (Malaysia)

^c Asia Metropolitan University   (Malaysia)

Author keywords

Free radicals; Lipid peroxidation; Malondialdehyde; Oxidative stress

Indexed keywords

EID: 84911473557     PISSN: 22516085     EISSN: 22516093     Source Type: Journal    
DOI: None     Document Type: Review

References (63)

1. Aruoma OI (1998). Free radicals, Oxidative stress ad antioxidants in human health and disease. J Am Oil Chem Soc, 75: 199-212.
2. Orrenius S, McConkey DJ, Bellomo G, Nicotera, P (1989). Role of Ca2+ in Toxic Cell Killing, Trends PharamacolSci, 10: 281-285.
3. Michiels C, Remacle J (1991). Cytotoxicity of linoleic acid peroxide, malondialdehyde and 4-hydroxynonenal towards human fibroblasts. Toxicology, 66: 225-234.
4. Brammer JP, Kerecsen L, Maguire M (1982). Effects of vinblastine on malondialdehyde formation, serotonin release and aggregation in human platelets. Eur J Pharmacol, 81: 577-585.
5. Smith JB, Ingerman CM, Silver MJ (1976). Malondialdehyde formation as an indicator of prostaglandin production by human platelets. J Lab Clin Med, 88: 167-172.
6. IARC (1985). IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans, Vol. 36, Allyl Compounds, Aldehydes, Epoxides and Peroxides, Lyon, pp. 163–177.
7. United States National Library of Medicine (1997). Hazardous Substances Data Bank (HSDB), Bethesda, MD Record No. 4353.
8. Chole RH, Patil RN, Basak A, Palandurkar K, Bhowate, R (2010). Estimation of serum malondialdehyde in oral cancer and precancer and its association with healthy individuals, gender, alcohol, and tobacco abuse. J Cancer Res Ther, 6: 487-491.
9. Zhang Y, Chen SY, Hsu T, Santella RM (2002). Immunohistochemical detection of malondialdehyde-DNA adducts in human oral mucosa cells. Carcinogenesis, 23: 207-211.
10. Mateos R, Goya L, Bravo L (2004). Determination of malondialdehyde by liquid chromatography as the 2, 4-dinitrophenylhydrazone derivative: a marker for oxidative stress in cell cultures of human hepatoma HepG 2. J Chromatogr B Analyt Technol Biomed Life Sci, 805: 33- 39.
11. Korchazhkina O, Exley C, Andrew, SS (2003). Measurement by reversed-phase highperformance liquid chromatography of malondialdehyde in normal human urine following derivatisation with 2,4-dinitrop henylhydrazine. J Chromatogr B Analyt Technol Biomed Life Sci, 794: 353-362.
12. Volpi N, Tarugi P (1998). Improvement in the high-performance liquid chromatography malondialdehyde level determination in normal human plasma. J Chromatogr B Biomed Sci Appl, 713:433-437.
13. Shin HS (2009). Determination of malondialdehyde in human blood by headspace-solid phase micro-extraction gas chromatographymass spectrometry after derivatization with 2,2,2-trifluoroethylhydrazine. J Chromatogr B Analyt Technol Biomed Life Sci, 877: 3707-371.
14. Fitzmaurice PS, Tong J, Yazdanpanah M et al. (2006). Levels of 4-hydroxynonenal and malondialdehyde are increased in brain of human chronic users of methamphetamine. J Pharmacol Exp Ther, 319: 703-709.
15. Requena JR, Fu MX, Ahmed MU et al. (1997). Quantification of malondialdehyde and 4- hydroxynonenal adducts to lysine residues in native and oxidized human low-density lipoprotein. Biochem J, 322 (1):317-325.
16. Sahin U, Unlu M, Ozgumer, MF, Taahan V, Akkaya, A (2001).Lipid peroxidation and erythrocyte superoxide dismutase activity in primary lung cancer. Biomed Res, 12: 13-6.
17. Jeny C, Goy J, Fechner J, Loeper J, Emerit J (1986). Study of lipid peroxidation by the assay of malondialdehyde in human and experimental atheroma. Presse Med, 15: 1131-1133.
18. Kakorin ID, Antonova OA, Balashov SA, Mel'kumiants AM (2010). Effect of malondialdehyde on deformability of human umbilical vein endothelial cells. Ross Fiziol Zh Im IM Sechenova, 96: 147-153.
19. Corbucci GG, Gasparetto A, Antonelli M, Bufi M, De Blasi RA (1986). Changes in the levels of coenzyme Q homologues, alphatocopherol and malondialdehyde in human tissue during the course of circulatory shock. Int J Tissue React, 8: 421-430.
20. Gwarzo MY, Muhammad SA (2010). Extracellular superoxide dismutase activity and plasma malondialdehyde in human immunodeficiency virus subjects of Kano state as surrogate markers of CD4 status. Int J Biomed Sci, 6: 294-300.
21. Karademir CB, Ozden S, Alpertunga B (2007). Effects of trichlorfon on malondialdehyde and antioxidant system in human erythrocytes. Toxicol In Vitro, 21: 1538-1544.
22. Akbulut H, Akbulut KG, Icli F, Buyukcelik A (2003). Daily variations of plasma malondialdehyde levels in patients with early breast cancer. Cancer Detect Prev, 27:122-126.
23. do Val Carneiro JL, Nixdorf SL, Mantovani MS et al. (2009). Plasma malondialdehyde levels and CXCR4 expression in peripheral blood cells of breast cancer patients. J Cancer Res Clin Oncol, 135:997-1004.
24. Macotpet A, Suksawat F, Sukon P et al. (2013). Oxidative stress in cancer-bearing dogs assessed by measuring serum malondialdehyde. BMC. Vet Res, 9:101.
25. Fischer SG, Perez RS, Nouta J et al.(2013). Oxidative Stress in Complex Regional Pain Syndrome (CRPS): No Systemically Elevated Levels of Malondialdehyde, F2-Isoprostanes and 8OHdG in a Selected Sample of Patients. Int J Mol Sci, 14: 7784-7794.
26. Fucile C, Marini V, Zuccoli ML et al. (2013). HPLC determination of malondialdehyde as biomarker for oxidative stress: application in patients with alcohol dependence. Clin Lab, 59: 837-841.
27. Karakurt AO, Ureten K, Sari M et al. (2013). Relationship of paraoxonase-1, malondialdehyde and mean platelet volume with markers of atherosclerosis in familial Mediterranean fever: an observational study. Anadolu Kardiyol Derg, 13: 357-362.
28. Matejckova J, Samec M, Samcova E, Rokyta R, Tuma P (2013). The effect of vitamin E on plasmatic malondialdehyde levels during surgical removal of ovarian and endometrial carcinomas. Eur J Gynaecol Oncol, 34: 329-331.
29. Nucci C, Di PD, Varesi C et al. (2013). Increased malondialdehyde concentration and reduced total antioxidant capacity in aqueous humor and blood samples from patients with glaucoma. Mol Vis,19:1841-1846.
30. Antus B, Harnasi G, Drozdovszky O, Barta I (2014). Monitoring oxidative stress during chronic obstructive pulmonary disease exacerbations using malondialdehyde. Respirology, 19: 74-79.
31. Schutt F, Bergmann M, Holz FG, Kopitz J (2003). Proteins modified by malondialdehyde, 4-hydroxynonenal, or advanced glycationend products in lipofuscin of human retinal pigment epithelium. Invest Ophthalmol Vis Sci, 44: 3663-3668.
32. Borchman D, Yappert MC, Rubini RQ, Paterson CA (1989). Distribution of phospholipidmalondialdehyde- adduct in the human lens. Curr Eye Res, 8: 939-946.
33. Yapicioglu H, Satar M, Canacankatan N et al. (2006). The effect of human growth hormone on superoxide dismutase activity, glutathione and malondialdehyde levels of hypoxicischemic newborn rat brain. Biol Neonate, 90: 168-173.
34. Lazzarino G, Tavazzi B, Di PD, Vagnozzi R, Penco M, Giardina B (1995). The relevance of malondialdehyde as a biochemical index of lipid peroxidation of postischemic tissues in the rat and human beings. Biol Trace Elem Res, 47: 165-170.
35. Janssen M, Koster JF, Bos E, de JongJW (1993). Malondialdehyde and glutathione production in isolated perfused human and rat hearts. Circ Res, 73: 681-688.
36. Das P, Choudhari AR, Singh AK, Singh R (2009). Correlation among routine semen parameters, sperm viabilty and malondialdehyde levels in human subjects with different fertility potential. Indian J Physiol Pharmacol, 53:253-258.
37. Gomez E, Irvine DS, Aitken RJ (1998). Evaluation of a spectrophotometric assay for the measurement of malondialdehyde and 4- hydroxyalkenals in human spermatozoa: relationships with semen quality and sperm function. Int J Androl, 21: 81-94.
38. Armas-Padilla MC, Armas-Hernandez MJ, Sosa- Canache B et al. (2007). Nitric oxide and malondialdehyde in human hypertension. Am J Ther, 14:172-176.
39. Mohan KS, Venkataramana G (2007). Status of lipid peroxidation, Glutathione, ascorbic acid, vitamin E & antioxidant enzymes in patients with pregnancy induced hypertension. Indian J physiol Pharmacol, 51(3): 284-88.
40. EI-Bana SM, ei-Din AE, Isamil ZA (2001). Fetal and maternal oxidative stress in normal and abnormlapregancis. Ain Shans Med J, 52: 421-31.
41. Dreissigacker U, Suchy MT, Maassen N, Tsikas D, (2010). Human plasma concentrations of malondialdehyde (MDA) and the F2- isoprostane 15(S)-8-iso-PGF (2alpha) may be markedly compromised by hemolysis: evidence by GC-MS/MS and potential analytical and biological ramifications. Clin Biochem, 43: 159-167.
42. Tesoriere L, D'Arpa D, Butera D et al.(2002). Exposure to malondialdehyde induces an early redox unbalance preceding membrane toxicity in human erythrocytes. Free Radic Res, 36:89-97.
43. Allegra M, Gentile C, Tesoriere L, Livrea MA (2002). Protective effect of melatonin against cytotoxic actions of malondialdehyde: an in vitro study on human erythrocytes. J Pineal Res, 32: 187-193.
44. Ponicke K, Forster W (1984). Influence of leukotriene C4 on aggregation and on malondialdehyde formation of human blood platelets. Biomed Biochim Acta, 43: S459-S462.
45. Serarslan G, Yilmaz HR, Sogut S (2005). Serum antioxidant activities, malondialdehyde and nitric oxide levels in human cutaneous leishmaniasis. Clin Exp Dermatol, 30:267-271.
46. Verma SP, Philippot JR, Bonnet B et al. (1985). Raman studies of structural rearrangements induced in human plasma lipoprotein carotenoids by malondialdehyde. Lipids, 20:890-896.
47. Kotani K, Maekawa M, Kanno T et al.(1994). Distribution of immunoreactive malondialdehyde- modified low-density lipoprotein in human serum. Biochim Biophys Acta, 1215:121-125.
48. Lecomte E, Artur Y, Chancerelle Y et al. (1993). Malondialdehyde adducts to, and fragmentation of, apolipoprotein B from human plasma. Clin Chim Acta, 218: 39-46.
49. Salmon S, Maziere C, Auclair M et al. (1992). Malondialdehyde modification and copperinduced auto-oxidation of high-density lipoprotein decrease cholesterol efflux from human cultured fibroblasts. Biochim Biophys Acta, 1125: 230-235.
50. Yang RL, Shi YH, Hao G, Li W, Le GW (2008). Increasing Oxidative Stress with Progressive Hyperlipidemia in Human: Relation between Malondialdehyde and Atherogenic Index. J Clin Biochem Nutr,43: 154-158.
51. Wang H, Msarnett LJ, Harris TM, Rizzo CJ (2004). A novel synthesis of malondialdehyde adducts of deoxyguaannosine, deoxyaadenosinne and deoxxycytidine. Chem Res Toxicol, 17: 144-149.
52. Sharma RA, Gescher A, Plastaras JP et al. (2001). Cyclooxygenase-2, malondialdehyde and pyrimidopurinone adducts of deoxyguanosine in human colon cells. Carcinogenesis, 22: 1557-1560.
53. Maddukuri L, Eoff RL, Choi JY, Rizzo CJ, Guengerich FP, Marnett LJ (2010). In vitro bypass of the major malondialdehyde- and base propenal-derived DNA adduct by human Y-family DNA polymerases kappa, iota, and Rev 1. Biochemistry, 49: 8415-8424.
54. Sun X, Nair J, Bartsch H (2004). A modified immuno-enriched 32P-postlabeling method for analyzing the malondialdehyde-deoxyguanosine adduct, 3-(2-deoxy-beta-Derythro- pentofuranosyl) - pyrimido1, 2alpha. purin-10(3H)one in human tissue samples. Chem Res Toxicol, 17:268-272.
55. Wang M, Dhingra K, Hittelman WN, Liehr JG, de A M, Li D (1996). Lipid peroxidationinduced putative malondialdehyde-DNA adducts in human breast tissues. Cancer Epidemiol Biomarkers Prev, 5: 705-710.
56. Rouzer CA, Chaudhary AK, Nokubo M, Ferguson DM, Reddy GR, Blair IA, Marnett LJ (1997). Analysis of the malondialdehyde-2'- deoxyguanosine adduct pyrimidopurinone in human leukocyte DNA by gas chromatography/ electron capture/negative chemical ionization/mass spectrometry. Chem Res Toxicol, 10: 181-188.
57. Niedernhofer LJ, Daniels JS, Rouzer CA, Greene RE, Marnett LJ (2003). Malondialdehyde, a product of lipid peroxidation, is mutagenic in human cells. J Biol Chem, 278: 31426-31433.
58. Wong SHY, Knight JA, Hopfer SH, Zaaharia O, Leach CN, Sunderland FW (1987). Lipoperoxides in plasma as measure by liquidchomatographic separation of malondialdehyde- thiobaarbituric acid adduct. Clin Chem, 33: 214–220.
59. Leuratti C, Singh R, Deag EJ, Griech E et al.(1999). A sensitive immunoslot-blot assay for detection of malondialdehydedeoxyguanosine in human DNA. IARC Sci Publ, 197-203.
60. Agarwal S, Wee JJ, Hadley M, Draper HH (1994). Identification of a deoxyguanosinemalondialdehyde adduct in rat and human urine. Lipids, 29:429-43.
61. Hadley M, Draper HH (1990). Isolation of a guanine-malondialdehyde adduct from rat and human urine. Lipids, 25: 82-85.
62. Xing D, Song N, Tan W (2001). Detection of malondialdehyde-DNA adduct level by 32Ppostlabeling assay in normal human esophageal epithelium and esophageal squamous cell carcinoma. Zhonghua Zhong Liu Za Zhi, 23: 473-476.
63. Leuratti C, Watson MA, Deag EJ et al. (2002). Detection of malondialdehyde DNA adducts in human colorectal mucosa: relationship with diet and the presence of adenomas. Cancer Epidemiol Biomarkers Prev, 11: 267-273.